Zhang Ping, Wang Yan, Liu Xue-Rong, Hong Shi-Ru, Yao Jian
Department of Integrated Traditional Chinese Medicine and Western Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Oncol Lett. 2018 Jul;16(1):1059-1066. doi: 10.3892/ol.2018.8697. Epub 2018 May 11.
The present study aimed to investigate the role of T cell immunoglobulin domain and mucin-3 (Tim-3) in its gene and protein forms in colorectal cancer (CRC), and to verify the significance of Tim-3 expression in patients with CRC. A prospective analysis of 258 patients with CRC and 246 normal controls was conducted between December 2012 and June 2015. Intestinal samples were collected, including of CRC tissues, paracancerous tissues and normal colon mucosa tissues. Peripheral venous blood samples were also collected. Polymerase chain reaction (PCR) amplification, reverse transcription-quantitative PCR (RT-qPCR) and western blot analysis was performed for the detection and evaluation of Tim-3 gene and protein in various tissues. PCR analysis indicated that the T and G alleles of -882C/T and 4259T/G are associated with a significantly increased risk of CRC. Following the confirmation of Tim-3 expression in CRC tissues, RT-qPCR detection and western blot analysis revealed clear downregulation of Tim-3 mRNA and protein expression in the blood and tissue samples obtained from patients with CRC, as compared with in the corresponding control samples. Similar trends of decreased Tim-3 mRNA levels and protein expression were observed in CRC tissues compared with in the paracancerous and the normal colon mucosa tissues. In addition, the mRNA and protein expression levels in the paracancerous tissues were lower than those in the normal colon mucosa tissues. Furthermore, significantly lower Tim-3 mRNA levels were observed in patients with a tumor size >5 cm, a poor differentiation degree, higher tumor-node-metastasis stage (stage III-IV), and lymph node and distant metastasis. Collectively, genetic changes to Tim-3, expressed as polymorphisms in Tim-3, and decreased mRNA/protein expression may be partially responsible for the incidence and development of CRC.
本研究旨在探讨T细胞免疫球蛋白结构域和黏蛋白3(Tim-3)的基因和蛋白形式在结直肠癌(CRC)中的作用,并验证Tim-3表达在CRC患者中的意义。2012年12月至2015年6月期间,对258例CRC患者和246例正常对照进行了前瞻性分析。收集肠道样本,包括CRC组织、癌旁组织和正常结肠黏膜组织。还收集外周静脉血样本。采用聚合酶链反应(PCR)扩增、逆转录定量PCR(RT-qPCR)和蛋白质印迹分析对不同组织中的Tim-3基因和蛋白进行检测和评估。PCR分析表明,-882C/T的T等位基因和4259T/G的G等位基因与CRC风险显著增加相关。在确认CRC组织中Tim-3表达后,RT-qPCR检测和蛋白质印迹分析显示,与相应对照样本相比,CRC患者血液和组织样本中Tim-3 mRNA和蛋白表达明显下调。与癌旁组织和正常结肠黏膜组织相比,CRC组织中也观察到Tim-3 mRNA水平和蛋白表达降低的类似趋势。此外,癌旁组织中的mRNA和蛋白表达水平低于正常结肠黏膜组织。此外,肿瘤大小>5 cm、分化程度差、肿瘤-淋巴结-转移分期较高(III-IV期)以及有淋巴结和远处转移的患者中,Tim-3 mRNA水平明显较低。总体而言,Tim-3的基因变化(表现为Tim-3多态性)以及mRNA/蛋白表达降低可能部分导致了CRC的发生和发展。